These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 11136352)

  • 1. Basal ganglia metabolite concentrations in idiopathic Parkinson's disease and multiple system atrophy measured by proton magnetic resonance spectroscopy.
    Clarke CE; Lowry M
    Eur J Neurol; 2000 Nov; 7(6):661-5. PubMed ID: 11136352
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Unchanged basal ganglia N-acetylaspartate and glutamate in idiopathic Parkinson's disease measured by proton magnetic resonance spectroscopy.
    Clarke CE; Lowry M; Horsman A
    Mov Disord; 1997 May; 12(3):297-301. PubMed ID: 9159722
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differentiation of multiple system atrophy from idiopathic Parkinson's disease using proton magnetic resonance spectroscopy.
    Davie CA; Wenning GK; Barker GJ; Tofts PS; Kendall BE; Quinn N; McDonald WI; Marsden CD; Miller DH
    Ann Neurol; 1995 Feb; 37(2):204-10. PubMed ID: 7847862
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Usefulness of proton magnetic resonance spectroscopy in differentiating parkinsonian syndromes.
    Federico F; Simone IL; Lucivero V; Mezzapesa DM; de Mari M; Lamberti P; Petruzzellis M; Ferrari E
    Ital J Neurol Sci; 1999 Aug; 20(4):223-9. PubMed ID: 10551908
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proton magnetic resonance spectroscopy (1H-MRS) of motor cortex and basal ganglia in de novo Parkinson's disease patients.
    Lucetti C; Del Dotto P; Gambaccini G; Bernardini S; Bianchi MC; Tosetti M; Bonuccelli U
    Neurol Sci; 2001 Feb; 22(1):69-70. PubMed ID: 11487206
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MRS study on lentiform nucleus in idiopathic Parkinson's disease with unilateral symptoms.
    Zheng XN; Zhu XC; Ruan LX; Zhang LJ; Yuan M; Shang DS; Liu Y
    J Zhejiang Univ Sci; 2004 Feb; 5(2):246-50. PubMed ID: 14674041
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Case control study: magnetic resonance spectroscopy of brain in HIV infected patients.
    Bairwa D; Kumar V; Vyas S; Das BK; Srivastava AK; Pandey RM; Sharma SK; Jagannathan NR; Sinha S
    BMC Neurol; 2016 Jul; 16():99. PubMed ID: 27405321
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A proton magnetic resonance spectroscopy study of the striatum and cerebral cortex in Parkinson's disease.
    Taylor-Robinson SD; Turjanski N; Bhattacharya S; Seery JP; Sargentoni J; Brooks DJ; Bryant DJ; Cox IJ
    Metab Brain Dis; 1999 Mar; 14(1):45-55. PubMed ID: 10348313
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Brainstem metabolites in multiple system atrophy of cerebellar type: 3.0-T magnetic resonance spectroscopy study.
    Takado Y; Igarashi H; Terajima K; Shimohata T; Ozawa T; Okamoto K; Nishizawa M; Nakada T
    Mov Disord; 2011 Jun; 26(7):1297-302. PubMed ID: 21370263
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantitative magnetic resonance spectroscopic imaging in Parkinson's disease, progressive supranuclear palsy and multiple system atrophy.
    Guevara CA; Blain CR; Stahl D; Lythgoe DJ; Leigh PN; Barker GJ
    Eur J Neurol; 2010 Sep; 17(9):1193-1202. PubMed ID: 20402762
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proton MR spectroscopy in idiopathic spasmodic torticollis.
    Federico F; Lucivero V; Simone IL; Defazio G; De Salvia R; Mezzapesa DM; Petruzzellis M; Tortorella C; Livrea P
    Neuroradiology; 2001 Jul; 43(7):532-6. PubMed ID: 11512580
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glutamate measurement in Parkinson's disease using MRS at 3 T field strength.
    Kickler N; Krack P; Fraix V; Lebas JF; Lamalle L; Durif F; Krainik A; Rémy C; Segebarth C; Pollak P
    NMR Biomed; 2007 Dec; 20(8):757-62. PubMed ID: 17334978
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Whole-brain proton MR spectroscopic imaging in Parkinson's disease.
    Levin BE; Katzen HL; Maudsley A; Post J; Myerson C; Govind V; Nahab F; Scanlon B; Mittel A
    J Neuroimaging; 2014; 24(1):39-44. PubMed ID: 23228009
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes in putamen N-acetylaspartate and choline ratios in untreated and levodopa-treated Parkinson's disease: a proton magnetic resonance spectroscopy study.
    Ellis CM; Lemmens G; Williams SC; Simmons A; Dawson J; Leigh PN; Chaudhuri KR
    Neurology; 1997 Aug; 49(2):438-44. PubMed ID: 9270574
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolite profile in the basal ganglia of children with cerebral palsy: a proton magnetic resonance spectroscopy study.
    Kulak W; Sobaniec W; Smigielska-Kuzia J; Kubas B; Walecki J
    Dev Med Child Neurol; 2006 Apr; 48(4):285-9. PubMed ID: 16542516
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolite changes and gender differences in schizophrenia using 3-Tesla proton magnetic resonance spectroscopy (1H-MRS).
    Tayoshi S; Sumitani S; Taniguchi K; Shibuya-Tayoshi S; Numata S; Iga J; Nakataki M; Ueno S; Harada M; Ohmori T
    Schizophr Res; 2009 Mar; 108(1-3):69-77. PubMed ID: 19097753
    [TBL] [Abstract][Full Text] [Related]  

  • 17. No change in striatal glutamate in Huntington's disease measured by proton magnetic resonance spectroscopy.
    Clarke CE; Lowry M; Quarrell OW
    Parkinsonism Relat Disord; 1998 Oct; 4(3):123-7. PubMed ID: 18591101
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolic Alterations Within the Primary Visual Cortex in Early Open-angle Glaucoma Patients: A Proton Magnetic Resonance Spectroscopy Study.
    Guo L; Wang R; Tang Z; Sun X; Wu L; Wang J; Zhong Y; Xiao Z; Zhang Z
    J Glaucoma; 2018 Dec; 27(12):1046-1051. PubMed ID: 30256276
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitative short echo time proton magnetic resonance spectroscopic imaging study of malformations of cortical development causing epilepsy.
    Woermann FG; McLean MA; Bartlett PA; Barker GJ; Duncan JS
    Brain; 2001 Feb; 124(Pt 2):427-36. PubMed ID: 11157569
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo 1H magnetic resonance spectroscopy-derived metabolite variations between acute-on-chronic liver failure and acute liver failure.
    Verma A; Saraswat VA; Radha Krishna Y; Nath K; Thomas MA; Gupta RK
    Liver Int; 2008 Sep; 28(8):1095-103. PubMed ID: 18266634
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.